Journal of Clinical Oncology, Vol 16, 3592-3600, Copyright © 1998 by American Society of Clinical Oncology

ARTICLES

Increased mortality after successful treatment for Hodgkin's disease

MM Hudson, CA Poquette, J Lee, CA Greenwald, A Shah, X Luo, EI Thompson, JA Wilimas, LE Kun and WM Crist
Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA. melissa.hudson@stjude.org

PURPOSE: To determine the impact of treatment toxicity on long-term survival in pediatric Hodgkin's disease. PATIENTS AND METHODS: We studied late events in 387 patients treated for pediatric Hodgkin's disease on four consecutive clinical trials at St Jude Children's Research Hospital from 1968 to 1990. Relative risks, actuarial risks, and absolute excess risks for cause-specific deaths were calculated. RESULTS: As of April 1997, 316 (82%) of patients were alive, with a median follow-up of 15.1 (range, 2.9 to 28.6) years. In this cohort, which represented 5,623 person-years of follow-up, 71 fatal events resulted from Hodgkin's disease (n=36), second malignancies (n=14), infections (n=7), accidents (n=7), cardiac disease (n=6), and asphyxiation (n=1). The 5-year estimated event-free survival (EFS) for the entire cohort was 79.6%+/-2.1 %, which declined to 63.1%+/-4.4% by 20 years. Cumulative incidences of cause-specific deaths at 25 years were 9.8%+/-1.6% for Hodgkin's disease, 8.1%+/-2.6% for second malignancy, 4.0%+/-1.8% for cardiac disease, 3.9%+/-1.5% for infection, and 2.1%+/-0.8% for accidents. Standardized incidence ratios showed excess risk for all second malignancies (12; 95% confidence interval [CI], 8 to 17), acute myeloid leukemia (81; 95% CI, 16 to 237), solid tumors (11; 95% CI, 7 to 16), and breast cancer (33; 95% CI, 12 to 72). Standardized mortality ratios also showed excess mortality from cardiac disease (22; 95% CI, 8 to 48) and infection (18; 95% CI, 7 to 38). CONCLUSION: Compared with age- and sex-matched control populations, survivors of pediatric Hodgkin's disease who were treated before 1990 face an increased risk of early mortality related to second cancers, cardiac disease, and infection.

This article has been cited by other articles:

				C. K. Tebbi, W. B. London, D. Friedman, D. Villaluna, P. A. De Alarcon, L. S. Constine, N. P. Mendenhall, R. Sposto, A. Chauvenet, and C. L. Schwartz Dexrazoxane-Associated Risk for Acute Myeloid Leukemia/Myelodysplastic Syndrome and Other Secondary Malignancies in Pediatric Hodgkin's Disease J. Clin. Oncol., February 10, 2007; 25(5): 493 - 500. [Abstract] [Full Text] [PDF]

				P. Das, A. K. Ng, C. C. Earle, P. M. Mauch, and K. M. Kuntz Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis Ann. Onc., May 1, 2006; 17(5): 785 - 793. [Abstract] [Full Text] [PDF]

				P. Das, A. K. Ng, M. A. Stevenson, and P. M. Mauch Clinical course of thoracic cancers in Hodgkin's disease survivors Ann. Onc., May 1, 2005; 16(5): 793 - 797. [Abstract] [Full Text] [PDF]

				S. Shankar, L. Robison, M. E.M. Jenney, T. H. Rockwood, E. Wu, J. Feusner, D. Friedman, R. L. Kane, and S. Bhatia Health-Related Quality of Life in Young Survivors of Childhood Cancer Using the Minneapolis-Manchester Quality of Life-Youth Form Pediatrics, February 1, 2005; 115(2): 435 - 442. [Abstract] [Full Text] [PDF]

				W. Landier, S. Bhatia, D. A. Eshelman, K. J. Forte, T. Sweeney, A. L. Hester, J. Darling, F. D. Armstrong, J. Blatt, L. S. Constine, et al. Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline J. Clin. Oncol., December 15, 2004; 22(24): 4979 - 4990. [Abstract] [Full Text] [PDF]

				M. M. Hudson, M. Krasin, M. P. Link, S. S. Donaldson, C. Billups, T. E. Merchant, L. Kun, A. L. Billet, S. Kaste, N. J. Tarbell, et al. Risk-Adapted, Combined-Modality Therapy With VAMP/COP and Response-Based, Involved-Field Radiation for Unfavorable Pediatric Hodgkin's Disease J. Clin. Oncol., November 15, 2004; 22(22): 4541 - 4550. [Abstract] [Full Text] [PDF]

				A. H. FRIEDLANDER, E. C. SUNG, and J. S. CHILD Radiation-induced heart disease after Hodgkin's disease and breast cancer treatment: Dental implications J Am Dent Assoc, December 1, 2003; 134(12): 1615 - 1620. [Abstract] [Full Text] [PDF]

				M. M. Hudson, A. C. Mertens, Y. Yasui, W. Hobbie, H. Chen, J. G. Gurney, M. Yeazel, C. J. Recklitis, N. Marina, L. R. Robison, et al. Health Status of Adult Long-term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study JAMA, September 24, 2003; 290(12): 1583 - 1592. [Abstract] [Full Text] [PDF]

				Y. Sharabi, R. Dendi, C. Holmes, and D. S. Goldstein Baroreflex Failure as a Late Sequela of Neck Irradiation Hypertension, July 1, 2003; 42(1): 110 - 116. [Abstract] [Full Text] [PDF]

				M. M. Hudson Pediatric Hodgkin's Therapy: Time for a Paradigm Shift J. Clin. Oncol., September 15, 2002; 20(18): 3755 - 3757. [Full Text] [PDF]

				R. T. Chlebowski, N. Col, E. P. Winer, D. E. Collyar, S. R. Cummings, V. G. Vogel III, H. J. Burstein, A. Eisen, I. Lipkus, and D. G. Pfister American Society of Clinical Oncology Technology Assessment of Pharmacologic Interventions for Breast Cancer Risk Reduction Including Tamoxifen, Raloxifene, and Aromatase Inhibition J. Clin. Oncol., August 1, 2002; 20(15): 3328 - 3343. [Abstract] [Full Text] [PDF]

				L. Diller, C. M. Nancarrow, K. Shaffer, U. Matulonis, P. Mauch, D. Neuberg, N. J. Tarbell, H. Litman, and J. Garber Breast Cancer Screening in Women Previously Treated for Hodgkin's Disease: A Prospective Cohort Study J. Clin. Oncol., April 15, 2002; 20(8): 2085 - 2091. [Abstract] [Full Text] [PDF]

				A. K. Ng, M. P. Bernardo, E. Weller, K. H. Backstrand, B. Silver, K. C. Marcus, N. J. Tarbell, J. Friedberg, G. P. Canellos, and P. M. Mauch Long-Term Survival and Competing Causes of Death in Patients With Early-Stage Hodgkin's Disease Treated at Age 50 or Younger J. Clin. Oncol., April 15, 2002; 20(8): 2101 - 2108. [Abstract] [Full Text] [PDF]

				T. R. Moller, S. Garwicz, L. Barlow, J. F. Winther, E. Glattre, G. Olafsdottir, J. H. Olsen, R. Perfekt, A. Ritvanen, R. Sankila, et al. Decreasing Late Mortality Among Five-Year Survivors of Cancer in Childhood and Adolescence: A Population-Based Study in the Nordic Countries J. Clin. Oncol., July 1, 2001; 19(13): 3173 - 3181. [Abstract] [Full Text] [PDF]

				C. S. Rhoads, J. G. Elmore, S. Fletcher, J. S. Spratt, P. M. Rosoff, K. Armstrong, A. Eisen, and B. Weber Assessing the Risk of Breast Cancer N. Engl. J. Med., June 29, 2000; 342(26): 2002 - 2003. [Full Text]